A brain network response to sham surgery.

Area of Science:

• Neuroscience
• Neurology
• Medical Research

Background:

• Evaluating neurological disease therapies is difficult due to significant placebo effects.
• Parkinson's disease (PD) serves as a key model for understanding the neurobiology of placebo responses.
• Placebo responses can introduce variability into clinical trial outcomes, complicating treatment evaluation.

Purpose of the Study:

• To identify the specific neural circuits underlying placebo responses in Parkinson's disease patients.
• To investigate the relationship between presurgical brain activity and subsequent placebo response.
• To explore the potential of identifying placebo responders to refine surgical trial designs.

Main Methods:

• Utilized neuroimaging techniques to measure metabolic activity in the brains of Parkinson's disease patients undergoing sham surgery.
• Correlated patterns of brain activity with observed motor improvements following the sham procedure.
• Analyzed the relationship between baseline neural activity and the magnitude of the placebo response.

Main Results:

• A specific neural circuit's metabolic activity increased and correlated with long-term motor improvements in patients receiving sham treatment.
• Presurgical activity within this identified network was inversely associated with the degree of sham response.
• This suggests a predictive marker for placebo responsiveness in Parkinson's disease.

Conclusions:

• A distinct neural circuit is associated with placebo effects in Parkinson's disease.
• This neural network may serve as a biomarker to identify individuals likely to respond to placebo interventions.
• Identifying sham responders could reduce placebo-related variance in surgical trials, enhancing therapeutic evaluation.